Video

In Small Stroke Patient Group TEMPO-1 Trial Shows Early Promise

Author(s):

Patients who come to a hospital following a stroke face a variety of challenges and complications. A recent study looked at a possible treatment for those who suffered only a mild or moderate stroke.

Patients who come to a hospital following a stroke face a variety of challenges and complications. A recent study looked at a possible treatment for those who suffered only a mild or moderate stroke.

Shelagh Coutts, MB, ChB, from the University of Calgary discussed the results of the TEMPO-1 Trial while at the International Stroke Conference in Nashville.

Related Videos
Confirming Tapinarof’s Efficacy and Safety Across Atopic Dermatitis Severities, with Justin Greiwe, MD
Investigating Briquilimab’s Efficacy and Safety for CSU, with Thomas Casale, MD
What to Look Forward to at the American Academy of Dermatology Annual Meeting 2025
Improving Care for ISM With Better Diagnosis, Disease Characterization, with Thanai Pongdee, MD
John Barbieri, MD, MBA | Credit: Brigham and Women's Hospital
Robert Wood, MD I Credit: Johns Hopkins Medicine
Achieving Chronic Spontaneous and Inducible Urticaria Control With Barzolvolimab, with Martin Metz, MD
Scott Commins, MD, PhD I Credit: UNC School of Medicine
Optimizing ISM Treatment Beyond Approval, with Vito Sabato, MBBS
Updated Treatment Strategies for Pediatric Atopic Dermatitis in 2025, with Ama Alexis, MD
© 2025 MJH Life Sciences

All rights reserved.